Literature DB >> 10688872

Molecular epidemiology: recent advances and future directions.

F P Perera1, I B Weinstein.   

Abstract

In 1982 we proposed the concept and a framework for implementing molecular cancer epidemiology. Here, we review progress during the past 17 years in validating and applying this approach to cancer prevention. There have been major advances, notably in the understanding of environment-susceptibility interactions in human cancer. However, a review of major findings to date reveals several urgent research needs to keep pace with the rapid evolution in knowledge of mechanisms in carcinogenesis. Although much valuable progress continues to be made in the study of carcinogens that cause direct DNA damage and are mutagenic, exogenous and endogenous carcinogens can also act by altering gene expression, cell proliferation and differentiation. The mechanisms include aberrant DNA methylation, oxidative damage, effects on metabolism of nitrogen oxide and nitrites, activation of receptors and transcription factors, cyclins and other cell cycle proteins. Sensitive, validated biomarkers are needed to detect these mechanisms in small numbers of cells, tissues or fluids. There is also increasing recognition that individual risk from carcinogen exposure varies as a function of both inherited and acquired factors. Recent advances in genomics, microassay technologies and informatics hold promise for rapid identification of polymorphic variants or changes in expression of genes influencing both response and susceptibility to carcinogens. Another emerging area of molecular epidemiology concerns the role of nutrition and specific dietary factors (including studies on antioxidants, energy metabolism, insulin and various growth factors) and the modulating effect of genetic polymorphisms. Finally, molecular epidemiology has enormous potential in cancer prevention through the early identification of 'at risk' populations and the rapid assessment of intervention efficacy. Its success in fully reaching this potential will depend on the application of validated biomarkers, with adherence to sound epidemiologic and ethical principles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688872     DOI: 10.1093/carcin/21.3.517

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

1.  Solution structure of the 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine C8-deoxyguanosine adduct in duplex DNA.

Authors:  K Brown; B E Hingerty; E A Guenther; V V Krishnan; S Broyde; K W Turteltaub; M Cosman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 2.  Biomarkers: potential uses and limitations.

Authors:  Richard Mayeux
Journal:  NeuroRx       Date:  2004-04

3.  In vitro tagging of embryos with nanoparticles.

Authors:  Tricia L Fynewever; Evelyn S Agcaoili; John D Jacobson; William C Patton; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2006-12-29       Impact factor: 3.412

4.  Association study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.

Authors:  Rubistenia Miranda Soares de Araújo; Cynthia Farias Vieira de Melo; Fidelis Manes Neto; Juarez Nóbrega da Silva; Leonardo Ferreira Soares; Marilia de Arruda Cardoso Smith; Edilson Carvalho Sousa; Rommel Mario Rodríguez Burbano; Arnaldo Correia de Medeiros; Eleonidas Moura Lima
Journal:  Tumour Biol       Date:  2014-01-23

Review 5.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 6.  Exosomes in bodily fluids are a highly stable resource of disease biomarkers.

Authors:  Stephanie Boukouris; Suresh Mathivanan
Journal:  Proteomics Clin Appl       Date:  2015-03-19       Impact factor: 3.494

7.  Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis.

Authors:  Li-Ping Zhou; Hong Luan; Xin-Hua Dong; Guo-Jiang Jin; Dong-Liang Man; Hong Shang
Journal:  Exp Ther Med       Date:  2011-05-31       Impact factor: 2.447

8.  The modified human DNA repair enzyme O(6)-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage.

Authors:  A K Teo; H K Oh; R B Ali; B F Li
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

9.  Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan B Okey; Patricia A Harper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

10.  GOVERNING GENETIC DATABASES: COLLECTION, STORAGE AND USE.

Authors:  Susan M C Gibbons; Jane Kaye
Journal:  Kings Law J       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.